|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.49 USD | -2.46% |
|
+2.74% | +50.06% |
| Mar. 06 | Nektar Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) | RE |
| Mar. 03 | Intellia Therapeutics Presents Longer-Term Clinical Data For Lonvoguran Ziclumeran | CI |
Quotes 5-day view: Intellia Therapeutics, Inc.
Delayed Quote Nasdaq
| 2026-04-06 | 2026-04-07 | 2026-04-08 | 2026-04-09 | 2026-04-10 | |
|---|---|---|---|---|---|
| Last | 13.30 $ | 13.55 $ | 13.87 $ | 13.83 $ | 13.49 $ |
| Volume | 1,943,374 | 2,344,076 | 3,015,570 | 1,427,254 | 1,809,407 |
| Change | +1.29% | +1.88% | +2.36% | -0.29% | -2.46% |
| Opening | 13.17 $ | 13.20 $ | 14.11 $ | 13.73 $ | 13.87 $ |
| High | 13.72 $ | 13.56 $ | 14.49 $ | 13.98 $ | 13.89 $ |
| Low | 13.17 $ | 12.85 $ | 13.57 $ | 13.62 $ | 13.28 $ |
Performance
| 1 day | -2.46% | ||
| 1 week | +2.74% | ||
| Current month | +5.23% | ||
| 1 month | +0.15% | ||
| 3 months | +29.96% | ||
| 6 months | -44.98% | ||
| Current year | +50.06% | ||
| 1 year | +99.26% | ||
| 3 years | -61.41% | ||
| 5 years | -80.90% |
Volumes
marketsDaily volume
1,809,407
Estimated daily volume
1,809,407
Avg. Volume 20 sessions
3,331,869
Daily volume ratio
0.54
Avg. Volume 20 sessions USD
44,946,912.81
Record volume 1
52,534,651
Record volume 2
25,413,219
Record volume 3
24,223,439
Capital turnover ratio
0.03
Float rotation
0.03
Basic data
Capitalization (USD)
1,593,621,535
Net sales (USD)
67,671,000
Number of employees
377
Sales / Employee (USD)
179,499
Free-Float
98.53 %
Free-Float capitalization (USD)
1,353,736,865
Average Daily Capital Traded
2.82%
Indicators
Moving average 5 days
13.61
Moving average 20 days
13.09
Moving average 50 days
13.06
Moving average 100 days
11.61
Price spread / (MMA5)
+0.87%
Price spread / (MMA20)
-2.94%
Price spread / (MMA50)
-3.20%
Price spread / (MMA100)
-13.93%
RSI 9 days
60.28
RSI 14 days
56.5
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.46% | +2.74% | +99.26% | -61.41% | 1.59B | |
| +1.74% | +0.55% | -1.27% | -9.27% | 45.62B | |
| -1.20% | -0.36% | +48.65% | +31.77% | 34.34B | |
| -0.89% | +2.25% | +26.48% | +33.05% | 29.46B | |
| -0.97% | -3.42% | +16.84% | -15.01% | 28.09B | |
| +0.22% | -2.71% | +186.40% | +369.47% | 19.11B | |
| -1.01% | +4.38% | +66.94% | +223.70% | 14.78B | |
| +2.31% | -6.43% | +3,777.83% | +3,935.28% | 14.25B | |
| -1.59% | -0.97% | +74.81% | +158.73% | 14.09B | |
| +0.25% | -4.10% | +37.01% | +4.36% | 13.25B | |
| Average | -0.36% | -0.83% | +433.30% | +467.07% | 21.46B | |
| Weighted average by Cap. | -0.08% | -0.78% | +293.39% | +325.59% |
Historical Quotes: Intellia Therapeutics, Inc.
| Date | Opening | High | Low | End-of-day | Volume | Change |
|---|
Latest transactions
a9bf54952624ec5809.0Vv-cEXiVSGSPviMcZUBaQqrDExzWH8gOhojS-AZPeA.h2i6Hn2qM2OrR6-1AKEwMXvBXRxFAS0ZUClJGJRAS9Xpdswcfa47TcgMmw
| Date | Price | Volume | Total |
|---|---|---|---|
| 04:00:00 pm | 13.49 | 196,532 | 1,326,021 |
| 03:59:59 pm | 13.50 | 122 | 1,129,489 |
| 03:59:59 pm | 13.50 | 100 | 1,129,367 |
| 03:59:59 pm | 13.50 | 100 | 1,129,267 |
| 03:59:59 pm | 13.49 | 100 | 1,129,167 |
| 03:59:59 pm | 13.50 | 100 | 1,129,067 |
| 03:59:58 pm | 13.49 | 100 | 1,128,967 |
| 03:59:57 pm | 13.49 | 100 | 1,128,867 |
| 03:59:57 pm | 13.49 | 100 | 1,128,767 |
| 03:59:57 pm | 13.49 | 100 | 1,128,667 |
Course Extremes
| 1 week | 12.85 |  | 14.49 |
| 1 month | 11.62 | | 14.49 |
| Current year | 9.05 | | 17.09 |
| 1 year | 6.73 | | 28.25 |
| 3 years | 5.9 | | 47.48 |
| 5 years | 5.9 | | 202.73 |
| 10 years | 5.9 | | 202.73 |
Monthly variations
Annual variations
| 2026 | +50.06% | ||
| 2025 | -22.90% | ||
| 2024 | -61.76% | ||
| 2023 | -12.61% | ||
| 2022 | -70.49% | ||
| 2021 | +117.35% | ||
| 2020 | +270.82% | ||
| 2019 | +7.47% | ||
| 2018 | -28.98% | ||
| 2017 | +46.61% | ||
| 2016 | -40.68% |
- Stock Market
- Equities
- NTLA Stock
- Quotes Intellia Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
